References
- Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol. 2015;16(8):461–472.
- Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat Cell Biol. 2018;20(3):233–242.
- Deng Z, Purtell K, Lachance V, et al. Autophagy Receptors and Neurodegenerative Diseases. Trends Cell Biol. 2017;27(7):491–504.
- Brier MR, Gordon B, Friedrichsen K, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Sci Transl Med. 2016;8(338):338ra66.
- Kaufman SK, Sanders DW, Thomas TL, et al. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Neuron. 2016;92(4):796–812.
- Sanders DW, Kaufman S, DeVos S, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014;82(6):1271–1288.
- Jaunmuktane Z, Mead S, Ellis M, et al. Erratum: evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 2015;526(7574):595.
- Purro SA, Farrow MA, Linehan J, et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 2018;564(7736):415–419.
- Irwin DJ, Abrams JY, Schonberger LB, et al. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol. 2013;70(4):462–468.
- Polanco JC, Li C, Durisic N, et al. Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons. Acta Neuropathol Commun. 2018;6(1):10.
- Evans LD, Wassmer T, Fraser G, et al. Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways. Cell Rep. 2018;22(13):3612–3624.
- Falcon B, Noad J, McMahon H, et al. Galectin-8–mediated selective autophagy protects against seeded tau aggregation. J Biol Chem. 2018;293(7):2438–2451.
- Bordi M, Berg MJ, Mohan PS, et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016;12(12):2467–2483.
- Carosi JM, Sargeant TJ. Rapamycin and Alzheimer disease: a double-edged sword? Autophagy. 2019;15(8):1460–1462.
- Hassiotis S, Manavis J, Blumbergs PC, et al. Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus. Eur J Neurosci. 2018;47(9):1043–1053.
- Whyte LS, Hassiotis S, Hattersley KJ, et al. Lysosomal Dysregulation in the Murine App Model of Alzheimer’s Disease. Neuroscience. 2020;429:143–155.
- Cui Y, Carosi JM, Yang Z, et al. Retromer has a selective function in cargo sorting via endosome transport carriers. J Cell Biol. 2019;218(2):615–631.
- Maruzs T, Lőrincz P, Szatmári Z, et al. Retromer Ensures the Degradation of Autophagic Cargo by Maintaining Lysosome Function in Drosophila. Traffic. 2015;16(10):1088–1107.
- Seaman MNJ. Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol. 2004;165(1):111–122.
- Arighi CN, Hartnell LM, Aguilar RC, et al. Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J Cell Biol. 2004;165(1):123–133.
- Steinberg F, Gallon M, Winfield M, et al. A global analysis of SNX27–retromer assembly and cargo specificity reveals a function in glucose and metal ion transport. Nat Cell Biol. 2013;15(5):461–471.
- Small SA, Kent K, Pierce A, et al. Model-guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol. 2005;58(6):909–919.
- Vagnozzi AN, Li J-G, Chiu J, et al. VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol Psychiatry. 2019. DOI:https://doi.org/10.1038/s41380-019-0453-x.
- Li JG, Chiu J, Pratico D. Full recovery of the Alzheimer’s disease phenotype by gain of function of vacuolar protein sorting. Mol Psychiatry. 2019;35. DOI: https://doi.org/10.1038/s41380-019-0364-x.
- Young JE, Fong LK, Frankowski H, et al. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer’s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports. 2018;10(3):1046–1058.
- Chen X, Kordich JK, Williams ET, et al. Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci U S A. 2019;116(12):5765–5774.
- Falcon B, Zhang W, Murzin AG, et al. Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature. 2018;561(7721):137–140.
- Fitzpatrick AWP, Falcon B, He S, et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature. 2017;547(7662):185–190.
- Zhang W, Tarutani A, Newell KL, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580(7802):283–287.
- Bolander A, Kieser D, Scholz C, et al. Synthesis of Methoxy-X04 Derivatives and Their Evaluation in Alzheimer’s Disease Pathology. Neurodegener Dis. 2014;13(4):209–213.
- Wallberg F, Tenev T, Meier P. Analysis of Apoptosis and Necroptosis by Fluorescence-Activated Cell Sorting. Cold Spring Harb Protoc. 2016;2016(4):pdb prot087387.
- Wlodkowic DT, Skommer J, Darzynkiewicz Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol. 2011;103:55–98.
- Kiladjian -J-J, Bourgeois E, Lobe I, et al. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia. 2006;20(3):463–470.
- Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222.
- Rubinsztein DC, Shpilka T, Elazar Z. Mechanisms of autophagosome biogenesis. Curr Biol. 2012;22(1):R29–34.
- Hanada T, Noda NN, Satomi Y, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem. 2007;282(52):37298–37302.
- Willems L, Chapuis N, Puissant A, et al. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia. 2012;26(6):1195–1202.
- Watanabe Y, Tanaka M. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. J Cell Sci. 2011;124(16):2692–2701.
- Yu Y, Run X, Liang Z, et al. Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neurochem. 2009;108(6):1480–1494.
- Ozdemir AY, Rom I, Kovalevich J, et al. PINCH in the cellular stress response to tau-hyperphosphorylation. PLoS One. 2013;8(3):e58232.
- Hein LK, Apaja PM, Hattersley K, et al. A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome. Biochim Biophys Acta Mol Cell Res. 2017;1864(10):1554–1565.
- Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3(5):452–460.
- Fuse A, Furuya N, Kakuta S, et al. VPS29-VPS35 intermediate of retromer is stable and may be involved in the retromer complex assembly process. FEBS Lett. 2015;589(13):1430–1436.
- Gieselmann V, Hasilik A, von Figura K. Processing of human cathepsin D in lysosomes in vitro. J Biol Chem. 1985;260(5):3215–3220.
- Vilarino-Guell C, Wider C, Ross O, et al. VPS35 mutations in Parkinson disease. The American Journal of Human Genetics. 2011;89(1):162–167.
- Cataldi S, Follett J, Fox JD, et al. Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice. Npj Parkinson’s Disease. 2018;4(1):27.
- Wang W, Wang X, Fujioka H, et al. Parkinson’s disease–associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat Med. 2016;22(1):54–63.
- Follett J, Bugarcic A, Yang Z, et al. Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces α-Synuclein Aggregation. J Biol Chem. 2016;291(35):18283–18298.
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259.
- Wen L, Tang F-L, Hong Y, et al. VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology. J Cell Biol. 2011;195(5):765–779.
- He Z, Guo JL, McBride JD, et al. Amyloid-beta plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24(1):29–38.
- Miura E, Hasegawa T, Konno M, et al. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson’s disease. Neurobiol Dis. 2014;71:1–13.
- Follett J, Norwood SJ, Hamilton NA, et al. The Vps35 D620N Mutation Linked to Parkinson’s Disease Disrupts the Cargo Sorting Function of Retromer. Traffic. 2014;15(2):230–244.
- Rojas R, van Vlijmen T, Mardones GA, et al. Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell Biol. 2008;183(3):513–526.
- Qureshi YH, Patel VM, Berman DE, et al. An Alzheimer’s Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol. 2018;38(20):e00011-18.
- Seaman MNJ. Retromer and the cation-independent mannose 6-phosphate receptor-Time for a trial separation? Traffic. 2018;19(2):150–152.
- Kvainickas A, Jimenez-Orgaz A, Nägele H, et al. Cargo-selective SNX-BAR proteins mediate retromer trimer independent retrograde transport. J Cell Biol. 2017;216(11):3677–3693.
- Simonetti B, Danson CM, Heesom KJ, et al. Sequence-dependent cargo recognition by SNX-BARs mediates retromer-independent transport of CI-MPR. J Cell Biol. 2017;216(11):3695–3712.
- Khurana V, Elson-Schwab I, Fulga TA, et al. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010;6(7):e1001026.
- Chen X, Li Y, Wang C, et al. Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy. Mol Neurodegener. 2020;15(1):2.
- Vaz-Silva J, Gomes P, Jin Q, et al. Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction. Embo J. 2018;37(20):e99084.
- Chen JJ, Nathaniel DL, Raghavan P, et al. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation. J Biol Chem. 2019;294(50):18952–18966.
- Brelstaff J, Tolkovsky AM, Ghetti B, et al. Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia. Cell Rep. 2018;24(8):1939–1948. e4.
- Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol. 1999;58(2):188–197.
- Kfoury N, Holmes BB, Jiang H, et al. Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem. 2012;287(23):19440–19451.
- Jankowsky JL, Zheng H. Practical considerations for choosing a mouse model of Alzheimer’s disease. Mol Neurodegener. 2017;12(1):89.
- Caballero B, Wang Y, Diaz A, et al. Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell. 2018;17(1):e12692.
- Verheyen A, Diels A, Dijkmans J, et al. Using Human iPSC-Derived Neurons to Model TAU Aggregation. PLoS One. 2015;10(12):e0146127.
- Gorantla NV, Chinnathambi S. Autophagic Pathways to Clear the Tau Aggregates in Alzheimer’s Disease. Cell Mol Neurobiol. 2020. DOI:https://doi.org/10.1007/s10571-020-00897-0
- Binder JL, Chander P, Deretic V, et al. Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons. PLoS One. 2020;15(3):e0230026.
- Mecozzi VJ, Berman DE, Simoes S, et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nat Chem Biol. 2014;10(6):443–449.
- Li J-G, Chiu J, Ramanjulu M, et al. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. Mol Neurodegener. 2020;15(1):1.
- Boyer LFC, Campbell B, Larkin S, et al. Dopaminergic Differentiation of Human Pluripotent Cells. Curr Protoc Stem Cell Biol. 2012;22(1). DOI:https://doi.org/10.1002/9780470151808.sc01h06s22
- Bardy C, van den Hurk M, Eames T, et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc Natl Acad Sci U S A. 2015;112(20):E2725–34.
- Bardy C, van den Hurk M, Kakaradov B, et al. Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology. Mol Psychiatry. 2016;21(11):1573–1588.
- Carosi JM, Hattersly K, Cui Y, et al. Subcellular Fractionation of Hela Cells for Lysosome Enrichment Using a Continuous Percoll-density Gradient. Bio-protocol. 2019;9(18):e3362.
- Polanco JC, Scicluna BJ, Hill AF, et al. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner. J Biol Chem. 2016;291(24):12445–12466.
- Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003;9(4):493–501.
- Scott KL, Kabbarah O, Liang M-C, et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature. 2009;459(7250):1085–1090.
- Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098–1101.